
About Logos Biosystems
Logos Biosystems is a publicly listed company based in Anyang (South Korea) founded in 2008. It manufactures digital imaging platforms and cell counters. Its website logosbio.com draws about 21 thousand monthly visits. Logos Biosystems offers products and services including LUNA-BX7™, LUNA-III™, CELENA® X, and X-CLARITY™. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Instruments and Diversified. Its legal entity is Aligned Genetics, Inc.
Company details
Logos Biosystems was founded in 2008 in Anyang, South Korea, where instruments for life science applications are manufactured. The product portfolio includes microbial cell counters for brightfield and fluorescence analysis, automated cell counters, and digital imaging systems such as CELENA S for fluorescence, brightfield, and phase contrast imaging. Systems and reagents for tissue clearing, like X-CLARITY, are also provided to support research operations in the biotechnology sector.
- Annual Revenue$11.09 M (USD)1.51as on Dec 31, 2025
- Net Profit$2.01 M (USD)-29.47as on Dec 31, 2025
- EBITDA$1.35 M (USD)-41.9as on Dec 31, 2025
Products & Services of Logos Biosystems
Logos Biosystems offers a comprehensive portfolio of products and services, including LUNA-BX7™, LUNA-III™, CELENA® X, and X-CLARITY™.
Device for brightfield cell counting in research labs.
Advanced tool for automated cell analysis and imaging.
System for high-content cell imaging applications.
Technology for tissue processing in scientific studies.
Apps and channels of Logos Biosystems
its YouTube channel LOGOS BIOSYSTEMS - Official Channel has 220 subscribers and 30 videos.
Videos from Logos Biosystems
The most watched videos on Logos Biosystems's YouTube channel, LOGOS BIOSYSTEMS - Official Channel (220 subscribers). Click a video to play it here.
More on LOGOS BIOSYSTEMS - Official Channel.
IPO & Listings of Logos Biosystems
Logos Biosystems is a publicly listed company on the KRX with ticker symbol 238120 in South Korea, operating in the Commercial services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date03 Nov 2016
- Listed onKRX: 238120
- Listed entityAligned Genetics, Inc.
- Exchange sectorCommercial services
- ISINKR7238120000
- Share price2,490.00 KRW (-1.39% on the day) · 2026-10-14
- Market capitalisation35,091,572,881.00 KRW
- Price to earnings7.5
- EPS (diluted, trailing year)330.19 KRW
- Volume (last session)8,988
Financials of Logos Biosystems
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 16.02B KRW | 2.91B KRW | 1.95B KRW |
| 2024 | 15.78B KRW | 4.13B KRW | 3.36B KRW |
| 2023 | 15.21B KRW | 3.24B KRW | 3.97B KRW |
| 2022 | 13.75B KRW | 2.33B KRW | 3.50B KRW |
| 2021 | 11.76B KRW | 5.54B KRW | 2.72B KRW |
Detailed financial statements for Logos Biosystems
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Web traffic of Logos Biosystems
The website of Logos Biosystems (logosbio.com) receives about 20.9K visits a month.
- Monthly visits20.9K
▼ 7.4% vs previous month
Websites whose visitors overlap most with Logos Biosystems. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
labmall.co.kr | labmall.co.kr | 100% | #443,821 | – | |
| discover-echo.com | 98% | 28.3K | #1,115,289 | View details | |
| bitesizebio.com | 88% | 153.3K | #313,861 | View details | |
| lifetechnologies.com | 87% | View details | |||
| selectscience.net | 86% | 117.5K | #363,624 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 13 similar websites and full traffic analytics for Logos Biosystems
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 13 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Logos Biosystems
Logos Biosystems was founded in 2008.
Logos Biosystems is headquartered in Anyang, South Korea. It is registered at Anyang, Gyeonggi-do, South Korea.
Annual revenue of Logos Biosystems is $11.09M as on Dec 31, 2025.
Logos Biosystems was founded in 2008 in Anyang, South Korea, where instruments for life science applications are manufactured. The product portfolio includes microbial cell counters for brightfield and fluorescence analysis, automated cell counters, and digital imaging systems such as CELENA S for fluorescence, brightfield, and phase contrast imaging. Systems and reagents for tissue clearing, like X-CLARITY, are also provided to support research operations in the biotechnology sector.
Logos Biosystems offers LUNA-BX7™, LUNA-III™, CELENA® X, and X-CLARITY™.
Yes, Logos Biosystems is publicly traded on KRX under the ticker symbol 238120.
Logos Biosystems operates through Aligned Genetics, Inc..